LFSC · F/m Emerald Life Sciences Innovation ETF
United States · RS rating 52 · As of 2026-10-14
| Price | 40.75 USD |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 52 / 23 / 33 / 85 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 34 / 54 / 18 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +15.9% |
| Market cap (USD) | – |